University of Queensland manufactures 3D printed scaffolding to rebuild jaw bones
On Jan. 9, 2025, clinicians from the The University of Queensland (UQ) announced they had successfully used custom-made…
Drug-resistant hookworms put pets and people at risk
On Jan. 7, 2025, scientists at The University of Queensland (UQ) and the University of Sydney announced they…
Study finds fluoride in water does not affect brain development
On Dec. 19, 2024, a University of Queensland (UQ) study has found no link between exposure to water…
Biotechnology | Diagnostics | Disease | Life Science News | Medical Device | Neurology | Therapeutics
University of Queensland ultrasound treatment for Alzheimer’s licensed to new startup
On Dec. 17, 2024, scientists at The University of Queensland (UQ) announced they had licensed a promising ultrasound…
Risk of depression and heart disease linked in women
On Dec. 5, 2025, researchers Dr Sonia Shah and Dr Clara Jiang from the University of Queensland’s Institute…
De-extinction company claimed it has nearly complete Tasmanian tiger Genome
On Oct. 17, 2024, Colossal Biosciences, an American biotechnology and genetic engineering company, announced that it has a…
CSIRO scientists Sequenced first full genome of critically endangered ‘Walking’ Australian Spotted handfish
On Oct. 8, 2024, scientists from the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia’s national science agency,…
World Health Organization confirmed case of human infection with avian influenza A(H5N1) virus in Australia
On May 22, 2024, the World Health Organization (WHO) announced that the first confirmed case of human infection…
Hugel Received FDA Approval in the U.S. of Letybo (letibotulinumtoxinA-wlbg) for Injection for Treatment of Glabellar Lines
On Mar. 4, 2024, Hugel America announced it received U.S. Food and Drug Administration (FDA) approval on its…
Australian government approved release of QUT-developed GM Cavendish QCAV-4
On Feb. 16, 2024, the Australian Government announced it had issued QUT a licence to commercially release QCAV-4,…
BioNTech and Australiaï¾’s State of Victoria signed agreement on strategic partnership to strengthen mRNA rcosystem
On Dec. 7, 2023, BioNTech announced that it had signed a multi-year strategic partnership with the State of…
Zimbabwe became first in Africa to announce regulatory approval for long-acting injectable cabotegravir for HIV prevention
On Nov. 1, 2022, the Medicines Control Authority of Zimbabwe announced that it had approved the use of…
Novavax Nuvaxovid COVID-19 vaccine recommended by CHMP for expanded conditional Marketing Authorization in EU as booster for adults
On Sept. 1, 2022, Novavax announced that Nuvaxovid (NVX-CoV2373) COVID-19 vaccine had been recommended for expanded conditional marketing…
Oldest clinical case of Klinefelter Syndrome was detected in a 1,000-year-old Portuguese skeleton
On Aug. 29, 2022, a group of international researchers, coordinated by Dr Jo�o Teixeira at The Australian National…
Novavax Nuvaxovid COVID-19 vaccine granted provisional registration in Australia for use in adolescents aged 12 through 17
On Jul. 26, 2022, Novavax announced that the Australian Therapeutic Goods Agency had granted expanded approval for provisional…
Australia TGA granted provisional approval for Moderna’s COVID-19 vaccine in children aged six months to five years
On Jul. 18, 2022, Moderna announced that the Therapeutic Goods Administration (TGA) in Australia had granted provisional registration…
Novavax COVID-19 vaccine Nuvaxovid provisionally registered in Australia as booster in individuals aged 18 and over
On Jun. 13 2022, Novavax announced that the Australian Therapeutic Goods Administration (TGA) had granted provisional registration of…
Novavax filed in the UK for expanded conditional Marketing Authorization of COVID-19 vaccination booster in adult
On Jun. 2, 2022, Novavax announced the submission of a request to the Medicines and Healthcare products Regulatory…
Multi-country outbreak reported in Twelve member nations not endemic for Mpox Virus
On May 21, 2022, the World Health Organization (WHO) reported that since May 13, 2022, cases of mpox…
Novavax submitted variations to expand Australian and New Zealand provisional approval of Nuvaxovid COVID-19 vaccine in Great Britain
On May 6, 2022, Novavax announced the submission of variations to the Australian Therapeutic Goods Agency (TGA) and…
Moderna finalized strategic partnership with Australian government
On Mar. 23, 2022, Moderna announced the finalization of a strategic partnership with the Australian Federal Government to…
Health Canada authorized Moderna’s COVID-19 vaccine in children (6-11 Years)
On Mar. 17, 2022, Moderna announced that Health Canada had approved the use of Moderna’s mRNA COVID-19 vaccine,…
Published study detailed proof-of-concept for COVID-19 detection via saliva screening
On Feb. 23, 2022, Agilent Technologies announced that researchers at the Indian Institute of Technology Bombay in India…
Therapeutic Goods Administration of Australia authorized Moderna’s Covid-19 vaccine in children (6-11 Years)
On Feb. 16, 2022, Moderna announced that the Therapeutic Goods Administration in Australia had granted provisional registration for…
Australia Therapeutic Goods Administration granted provisional registration for Novavax COVID-19 vaccine
On Jan. 19, 2022, Novavaxa announced that Australia’s Therapeutic Goods Administration had granted approval for provisional registration of…
Moderna and Australia announced collaboration to bring mRNA manufacturing to Australia
On Dec. 13, 2021, Moderna announced an agreement with the Australian Government to build a state-of-the-art messenger RNA…
Novavax filed for provisional approval of its COVID-19 vaccine in Australia
On Oct. 29, 2021, Novavax announced the completion of its rolling submission to the Therapeutic Goods Administration (TGA)…
Researchers developed COVID-19 severity screening method based on the Agilent Cary 630 FTIR spectrometer
On Aug. 18, 2021, Agilent Technologies announced that researchers at the Indian Institute of Technology Bombay in India…
Australian Therapeutic Goods Administration granted provisional registration for Moderna’s COVID-19 vaccine
On Aug. 9, 2021, Moderna announced that the Therapeutic Goods Administration (TGA) had granted provisional registration to the…
Moderna announced new supply agreement with Australia for 25 million doses of its COVID-19 vaccine
On May 12, 2021, Moderna announced a new supply agreement with the government of Australia for 25 million…